Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xtandi
Pharma
Lawmakers blast Biden administration's 'march-in' proposal
A group of lawmakers warned that the Biden administration's use of so-called "march-in" rights to lower drug prices could “hamstring” U.S. innovation.
Fraiser Kansteiner
Feb 23, 2024 9:53am
JPM24: Pfizer oncology head still eyes ADC deals under new org
Jan 11, 2024 11:03am
'March-in' drug pricing provisions advance in the US
Dec 7, 2023 11:58am
AstraZeneca, BeiGene, Coherus—Fierce Pharma Asia
Dec 1, 2023 8:34am
FDA adds uses for Merck's Keytruda, Pfizer and Astellas' Xtandi
Nov 17, 2023 11:18am
ESMO: Novartis' Pluvicto posts mixed prostate cancer data
Oct 23, 2023 10:30am